Riente, L. “The Safety of Interleukin-1 Receptor Antagonist (anakinra) in the Treatment of Rheumatoid Arthritis”. Reumatismo 56, no. s1 (March 30, 2004): 74–79. Accessed February 8, 2025. https://www.reumatismo.org/reuma/article/view/reumatismo.2004.1s.74.